Navellier & Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-24,611
| Closed | -$206K | – | 364 |
|
|
2021
Q4 | $206K | Buy |
24,611
+12,995
| +112% | +$109K | 0.03% | 303 |
|
|
2021
Q3 | $86K | Sell |
11,616
-451
| -4% | -$3.34K | 0.01% | 307 |
|
|
2021
Q2 | $82K | Sell |
12,067
-92
| -0.8% | -$625 | 0.01% | 296 |
|
|
2021
Q1 | $125K | Hold |
12,159
| – | – | 0.02% | 279 |
|
|
2020
Q4 | $85K | Sell |
12,159
-657
| -5% | -$4.59K | 0.02% | 272 |
|
|
2020
Q3 | $105K | Buy |
12,816
+160
| +1% | +$1.31K | 0.02% | 222 |
|
|
2020
Q2 | $87K | Buy |
+12,656
| New | +$87K | 0.02% | 228 |
|